Thursday, 19 March 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Sport
Culture
Opinion
Environment
← Back to headlines
Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
19 Mar, 11:44 — 19 Mar, 11:44
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
seeking-alpha
Mixed
1h ago
Pfizer posts late-stage trial win for Talzenna plus Xtandi in new prostate cancer indication
Read full article →
Something wrong with this story? Report an issue
Related Stories
Pangasinan logs lowest stunting rate in PH
just now
Doctors’ reluctance to accept postings to deprived areas serious – Health Ministry
7m ago
Engineering student found dead in hostel room at Medipally
12m ago
Latvijā viens no zemākajiem priekšlaicīgu dzemdību rādītājiem Eiropā. Ko darām pareizi?
13m ago
Thursday, 19 March 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
